Genetics of scleroderma: implications for personalized medicine?
<p>Abstract</p> <p>Significant advances have been made in understanding the genetic basis of systemic sclerosis (scleroderma) in recent years. Can these discoveries lead to individualized monitoring and treatment? Besides robustly replicated genetic susceptibility loci, several gen...
Main Authors: | Assassi Shervin, Radstake Timothy RDJ, Mayes Maureen D, Martin Javier |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2013-01-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1741-7015/11/9 |
Similar Items
-
Scleroderma with Nodular Scleroderma
by: Chutika Srisuttiyakorn, et al.
Published: (2016-11-01) -
Nationwide and international registries on scleroderma. Past, present, and future
by: Manuel Rubio-Rivas
Published: (2021-07-01) -
Multiomic study of skin, peripheral blood, and serum: is serum proteome a reflection of disease process at the end-organ level in systemic sclerosis?
by: Victor Farutin, et al.
Published: (2021-10-01) -
Drug-induced scleroderma-like lesion
by: Yasuhito Hamaguchi
Published: (2022-04-01) -
Systemic Sclerosis Sine Scleroderma Manifested with Gastrointestinal Bleeding, Antiphospholipid Syndrome and Positive Anti-RNA Polymerase III Antibody: Case Report and Literature Review
by: Alghamdi M, et al.
Published: (2020-08-01)